Aquatic Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$196K Sell
6,875
-14,450
-68% -$315K 0.01% 1009
2026
Q1
$370K Sell
21,325
-30,751
-59% -$582K 0.01% 843
2025
Q4
$981K Sell
52,076
-37,666
-42% -$631K 0.03% 554
2025
Q3
$1.3M Buy
89,742
+87,738
+4,378% +$1.25M 0.02% 594
2025
Q2
$39.2K Buy
+2,004
New +$35.6K ﹤0.01% 1160
2025
Q1
– Sell
-24,083
Closed -$516K – 1299
2024
Q4
$516K Buy
+24,083
New +$586K 0.01% 710
2022
Q4
– Sell
-9,300
Closed -$158K – 1412
2022
Q3
$158K Buy
9,300
+4,300
+86% +$92.3K 0.02% 660
2022
Q2
$107K Buy
5,000
+4,900
+4,900% +$136K 0.03% 466
2022
Q1
$4K Buy
+100
New +$3.9K 0.01% 853

Other funds holding CDNA

Aquatic Capital Management's CDNA Position: Q2 2026 in Review

Aquatic Capital Management reduced its CareDx (CDNA) stake by 68% in Q2 2026, selling an estimated $315K and leaving 6,875 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #1009.

Aquatic Capital Management first reported a position in CDNA in Q1 2022 and has held it in 9 quarters since. The position peaked at $1.3M in Q3 2025. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Aquatic Capital Management held 6,875 shares of CareDx worth $196K as of Q2 2026.
  • Aquatic Capital Management sold 14,450 CareDx shares in Q2 2026, an estimated $315K.
  • CareDx made up 0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1009 holding.
  • Aquatic Capital Management first reported a position in CareDx in Q1 2022 and has held it in 9 quarters since.
  • Aquatic Capital Management's CareDx position peaked at $1.3M in Q3 2025.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.